EPO | GenomeWeb

EPO

NEW YORK (GenomeWeb) – Benitec Biopharma this week announced that it is appealing the European Patent Office's recent revocation of a patent covering the company's core expressed RNAi technology, which had been successfully challenged by biotech firm Galapagos and agro-chemical giant BASF.

NEW YORK (GenomeWeb) – Benitec Biopharma last week announced that the European Patent Office has upheld its previous decision to revoke one of the company's core patents based on opposition filed by biotech firm Galapagos and chemical giant BASF.

Alnylam Pharmaceuticals this week announced that the European Patent Office has upheld a company patent related to chemically modified siRNAs and their ability to downregulate target genes via RNAi.

Marina Biotech this week said that the US Patent and Trademark Office has issued a notice of allowance for three of the company's patent applications related to its delivery technologies.

Rosetta Genomics this week announced that it has received a patent allowance from the European Patent Office for claims related to the use of microRNA-34a for the treatment of p53-negative cancers.

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Dutch agricultural genetics firm KeyGene today said that its patent pertaining to plant breeding has been upheld in Europe.

Silence Therapeutics last week publicly took issue with Alnylam Pharmaceuticals' claims regarding a European patent opposition, stating that the European Patent Office had limited the “scope and ambiguity” of an Alnylam-controlled patent.

Alnylam Pharmaceuticals and the University of Massachusetts Medical School last week announced that the European Patent Office has upheld the claims in a patent from the key Tuschl-I family of intellectual property, which covers the use of siRNAs to induce gene silencing.

Pages

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.